Symbol Name ID |
Slc19a2
solute carrier family 19 (thiamine transporter), member 2 MGI:1928761 |
Darker colors indicate more annotations |
Human Phenotypes | Decreased CSF 5-methyltetrahydrofolate concentration |
Increased circulating lactate dehydrogenase concentration |
Diabetes mellitus |
Abnormal blood folate concentration |
Decreased circulating vitamin B12 concentration |
Malabsorption of Vitamin B12 |
Microscopic hematuria |
Proteinuria |
Aminoaciduria |
Disease(s) Associated with SLC19A2 | |||||||||
megaloblastic anemia | |||||||||
thiamine-responsive megaloblastic anemia syndrome |
Mouse Phenotypes | decreased circulating insulin level |
impaired glucose tolerance |
increased insulin sensitivity |
|
Availability | Mouse Genotype | |||
Slc19a2tm1Gelb/Slc19a2tm1Gelb |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/30/2024 MGI 6.23 |
|
|